ISRCTN35919612已完成不适用
Maintenance therapy in patients with severe Systemic lupus erythematosus (SLE): The BILAG multi-centre open randomised controlled trial comparing cyclosporin A and azathioprine
Arthritis Research Campaign (ARC) (UK)0 个研究点目标入组 89 人开始时间: 2002年7月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 89
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. American Rheumatism Association (ARA) criteria for SLE
- •2. New corticosteroid sparing agent required
- •3. Patient on 15 mg or more of prednisolone for at least 4 weeks
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
招募中
2 期
ong term follow up of patients with severe Systemic Sclerosis (SSc) and Rheumatoid Arthritis (RA) who have undergone Haematopoietic Stem Cell Transplantation (HSCT).Systemic Sclerosis and Rheumatoid ArthritisInflammatory and Immune System - Autoimmune diseasesACTRN12611000826943St Vincents Hospital, Sydney25
招募中
不适用
RAdiotherapy in combination with Maintenance Systemic pegylated Interferon therapy for Mycosis FungoideS (RAMSIS)C84Mature T/NK-cell lymphomasDRKS00031975niversitätsklinikum Münster56
进行中（未招募）
1 期
ODM-201 maintenance therapy in patients with mCRPC previously treated with novel hormonal agentsEUCTR2016-003996-23-ESSAKK88
进行中（未招募）
1 期
ODM-201 maintenance therapy in patients with mCRPC previously treated with novel hormonal agentsMetastatic castration resistant prostate cancerMedDRA version: 20.0Level: LLTClassification code 10007453Term: Carcinoma of the prostate metastaticSystem Organ Class: 100000004864EUCTR2016-003996-23-ITSAKK88
进行中（未招募）
1 期
ODM-201 maintenance therapy in patients with mCRPC previously treated with novel hormonal agentsEUCTR2016-003996-23-FRSAKK92